In the last trading session, 1.87 million Larimar Therapeutics Inc (NASDAQ:LRMR) shares changed hands as the company’s beta touched 0.80. With the company’s per share price at $2.91 changed hands at $0.25 or 9.40% during last session, the market valuation stood at $186.32M. LRMR’s last price was a discount, traded about -284.88% off its 52-week high of $11.20. The share price had its 52-week low at $1.61, which suggests the last value was 44.67% up since then.
Analysts gave the Larimar Therapeutics Inc (LRMR) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.08. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended LRMR as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight.
Larimar Therapeutics Inc (NASDAQ:LRMR) trade information
Instantly LRMR was in green as seen at the end of in last trading. With action 20.75%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -24.81%, with the 5-day performance at 20.75% in the green. However, in the 30-day time frame, Larimar Therapeutics Inc (NASDAQ:LRMR) is 37.26% up.
The consensus price target for the stock as assigned by Wall Street analysts is 15, meaning bulls need an upside of 80.6% from its current market value. According to analyst projections, LRMR’s forecast low is 15 with 15 as the target high. To hit the forecast high, the stock’s price needs a -415.46% plunge from its current level, while the stock would need to soar -415.46% for it to hit the projected low.
Larimar Therapeutics Inc (LRMR) estimates and forecasts
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 50.78%. The 2025 estimates are for Larimar Therapeutics Inc earnings to decrease by -46.00%, but the outlook for the next 5-year period is at -7.85% per year.
Larimar Therapeutics Inc (NASDAQ:LRMR)’s Major holders
RA CAPITAL MANAGEMENT, L.P. holds the second largest percentage of outstanding shares, with 9.4752% or 6.05 million shares worth $43.83 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF. With 1.31 shares estimated at $3.8 million under it, the former controlled 2.04% of total outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held about 1.63% of the shares, roughly 1.04 shares worth around $3.03 million.
